(Q40407184)

20 September 2017

1 reference

title

MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials (English)

1 reference

20 September 2017

1 reference

1 reference

20 September 2017

language of work or name

1 reference

1 August 1995

1 reference

20 September 2017

published in

Quality of Life Research

1 reference

20 September 2017

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

343-352

1 reference

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

20 September 2017

cites work

1 reference

12 December 2020

Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life.

1 reference

12 December 2020

A daily diary for quality of life measurement in advanced breast cancer trials

1 reference

12 December 2020

Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small-cell lung cancer

1 reference

12 December 2020

Night cough counts and diary card scores in asthma

1 reference

12 December 2020

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Wor

1 reference

12 December 2020

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Medical Research Council Lung Cancer Working Party

1 reference

12 December 2020

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

1 reference

12 December 2020

Quality of life consequences of chemotherapy-induced emesis

1 reference

12 December 2020

Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland

1 reference

12 December 2020

Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment

1 reference

12 December 2020

Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Quality of life assessment in clinical trials: methodologic issues

1 reference

12 December 2020

Measuring and analysing quality of life in cancer clinical trials: a review.

1 reference

12 December 2020

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

12 December 2020

Quality-of-Life Assessment: Patient Compliance With Questionaire Completion

1 reference

12 December 2020

The hospital anxiety and depression scale

1 reference

12 December 2020

Sickness Impact Profile: the state of the art of a generic functional status measure

1 reference

12 December 2020

A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

1 reference

12 December 2020

Statistical analysis of longitudinal quality of life data with missing measurements

1 reference

12 December 2020

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Part

1 reference

12 December 2020

Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status

1 reference

12 December 2020

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

12 December 2020

1 reference

12 December 2020

Centralised treatment, entry to trials and survival

1 reference

12 December 2020

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party

1 reference

12 December 2020

Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer

1 reference

12 December 2020

Patient compliance with oral chemotherapy as assessed by a novel electronic technique

1 reference

12 December 2020

Interviewer versus self-administered questionnaires in developing a disease-specific, health-related quality of life instrument for asthma

1 reference

12 December 2020

Lessons learned from measuring health-related quality of life in oncology

1 reference

12 December 2020

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer

1 reference

12 December 2020

Generalizing the results of randomized clinical trials

1 reference

12 December 2020

Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia

1 reference

12 December 2020

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

12 December 2020

Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial

1 reference

12 December 2020

The roles of patient and observer assessments in anti-emetic trials

1 reference

12 December 2020

Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01593887

1 reference

Dimensions Publication ID

20 September 2017

1037278872

0 references

1 reference